These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16202485)

  • 1. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.
    Shen T; Liang H; Tong X; Fan X; He X; Ma Y; Xiang W; Shen R; Zhang X; Shao Y
    Vaccine; 2006 Feb; 24(6):738-49. PubMed ID: 16202485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV.
    Liang H; He X; Shen RX; Shen T; Tong X; Ma Y; Xiang WH; Zhang XY; Shao YM
    Arch Virol; 2006 Jul; 151(7):1387-403. PubMed ID: 16502285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Kong X; Zhou J
    Arch Virol; 2011 Feb; 156(2):353-7. PubMed ID: 21136127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long terminal repeat sequences from virulent and attenuated equine infectious anemia virus demonstrate distinct promoter activities.
    Zhou T; Yuan XF; Hou SH; Tu YB; Peng JM; Wen JX; Qiu HJ; Wu DL; Chen HC; Wang XJ; Tong GZ
    Virus Res; 2007 Sep; 128(1-2):58-64. PubMed ID: 17499380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long terminal repeats are not the sole determinants of virulence for equine infectious anemia virus.
    Tu YB; Zhou T; Yuan XF; Qiu HJ; Xue F; Sun CQ; Wang L; Wu DL; Peng JM; Kong XG; Tong GZ
    Arch Virol; 2007 Jan; 152(1):209-18. PubMed ID: 16932982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
    Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
    Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.
    Fagerness AJ; Flaherty MT; Perry ST; Jia B; Payne SL; Fuller FJ
    Virology; 2006 May; 349(1):22-30. PubMed ID: 16503341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
    Raabe ML; Issel CJ; Montelaro RC
    Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse mutation of the virulence-associated S2 gene does not cause an attenuated equine infectious anemia virus strain to revert to pathogenicity.
    Gao X; Jiang CG; Wang XF; Lin YZ; Ma J; Han XE; Zhao LP; Shen RX; Xiang WH; Zhou JH
    Virology; 2013 Sep; 443(2):321-8. PubMed ID: 23763769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid mutations in the env gp90 protein that modify N-linked glycosylation of the Chinese EIAV vaccine strain enhance resistance to neutralizing antibodies.
    Han X; Zou J; Wang X; Guo W; Huo G; Shen R; Xiang W
    Viral Immunol; 2010 Oct; 23(5):531-9. PubMed ID: 20883167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and in vitro evaluation of an infectious clone of the equine infectious anemia virus vaccine strain EIAV(FDDV) with four reverse-mutated vaccine-specific sites in the S2 gene].
    Gao X; Jiang CG; Han XE; Zhao LP; Shen RX; Xiang WH; Zhou JH
    Bing Du Xue Bao; 2009 Jul; 25(4):309-15. PubMed ID: 19769166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity.
    Jiang CG; Gao X; Ma J; Lin YZ; Wang XF; Zhao LP; Hua YP; Liu D; Zhou JH
    Virus Res; 2011 Jun; 158(1-2):235-45. PubMed ID: 21539871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?
    Leroux C; Cadoré JL; Montelaro RC
    Vet Res; 2004; 35(4):485-512. PubMed ID: 15236678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proviral derivative from a reference attenuated EIAV vaccine strain failed to elicit protective immunity.
    Ma J; Shi N; Jiang CG; Lin YZ; Wang XF; Wang S; Lv XL; Zhao LP; Shao YM; Kong XG; Zhou JH; Shen RX
    Virology; 2011 Feb; 410(1):96-106. PubMed ID: 21094511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy.
    Craigo JK; Li F; Steckbeck JD; Durkin S; Howe L; Cook SJ; Issel C; Montelaro RC
    J Virol; 2005 Mar; 79(5):2666-77. PubMed ID: 15708986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of an infectious clone of equine infectious anemia virus by N-glycosylation reverse-mutations].
    Han X; Quan Y; Gao X; Xiang W; Zhou J
    Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):287-92. PubMed ID: 18479052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
    Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
    Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
    Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus.
    Hammond SA; Cook SJ; Falo LD; Issel CJ; Montelaro RC
    Virology; 1999 Feb; 254(1):37-49. PubMed ID: 9927572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.